For HCC, three main targets have been explored, which are programmed cell death protein-1 (PD-1), programmed cell death ligand-1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) [11,12,13]. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.